Chemical Compound
4-Quinolinecarboxamide, 2-butoxy-N-[2-(diethylamino)ethyl]-; Cinchoninamide, 2-butoxy-N-[2-(diethylamino)ethyl]- (8CI); 2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide; 2-Butoxy-N-[2-(diethylamino)ethyl]cinchoninamide; 2-Butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide; Cinchocaine; Dermacaine; Dibucaine; Dibucaine base; N-[2-(Diethylamino)ethyl]-2-butoxycinchoninamide; NSC 159055; Nupercainal; Nupercaine; Percamine
CAS Registry Number
85-79-0
Primary record
4-Quinolinecarboxamide, 2-butoxy-N-[2-(diethylamino)ethyl]-; Cinchoninamide, 2-butoxy-N-[2-(diethylamino)ethyl]- (8CI); 2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide; 2-Butoxy-N-[2-(diethylamino)ethyl]cinchoninamide; 2-Butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide; Cinchocaine; Dermacaine; Dibucaine; Dibucaine base; N-[2-(Diethylamino)ethyl]-2-butoxycinchoninamide; NSC 159055; Nupercainal; Nupercaine; Percamine
- 库存
- 9,875 克
- 纯度
- 99.1 %
- CAS
- 85-79-0
化合物标识与属性
- CAS
- 85-79-0
- PubChem CID
- 3025
- SMILES
- CCCCOC1=NC2=CC=CC=C2C(=C1)C(=O)NCCN(CC)CC
- Canonical SMILES
- CCCCOc1cc(C(=O)NCCN(CC)CC)c2ccccc2n1
名称与同义词
- dibucaine
- Cinchocaine
- Nupercainal
- Nupercaine
- Dermacaine
- Sovcaine
- Dibucaine Base
- Dibucain
- Percamine
- Cinchocainum
- Cincocaina
- Cincocainio
- 85-79-0
- Dibucainum
- Cincainum
- Cincain
- Dibucaine [USP]
- Nupercainal (VAN)
- Dibucaine HCl
- Dibucaine hydrochloride
- Cinchocaine HCL
- Cincocaina [DCIT]
- Dibucaine (USP)
- cinchocain-
- Nupercaine (TN)
- Percamine S
- Cincaine chloride
- Cinchocaine (INN)
- Cinchocaine [INN]
- Dibucaine 1%
- Nupercainal (TN)
- Cinchocaine hydrochloride
- Cinchocainum [INN-Latin]
- Sovcaine (TN)
- Cinchocaine(Dibucaine)
- Prestwick_164
- Cincain (TN)
- Cinchocaine - USP
- Cincocainio [INN-Spanish]
- Dibucaine (Standard)
- Cinchocaine; Dibucaine
- 2-butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide
- L6JW2TJG99
- Spectrum_000928
- Opera_ID_192
- RefChem:58586
- UNII-L6JW2TJG99
- DIBUCAINE [MI]
- DTXSID3045271
- DIBUCAINE [HSDB]
- Heavy Solution Nupercaine
- Prestwick0_000076
- Prestwick1_000076
- Prestwick2_000076
- Prestwick3_000076
- Spectrum2_001001
- Spectrum3_000384
- Spectrum4_000505
- Spectrum5_000865
- AMLODIPINE BESYLATE
- DIBUCAINE [VANDF]
- C20H29N3O2
- D0P5GE
- HSDB 3312
- Dibucaine(Cinchocaine) Base
- MLS000028425
- PUFQVTATUTYEAL-UHFFFAOYSA-N
- CHEMBL1086
- CINCHOCAINE [MART.]
- Dibucaine (Cinchocaine) HCl
- SCHEMBL34473
- BSPBio_000291
- BSPBio_002167
- CINCHOCAINE [WHO-DD]
- DTXCID1025271
- KBioGR_001049
- KBioSS_001408
- MLS000028429
- MLS001148085
- DivK1c_000332
- NSC 159055
- NSC-159055
- CHEBI:247956
- EINECS 201-632-1
- SPBio_001121
- SPBio_002212
- MFCD00047595
- AC1L1F05
- BPBio1_000321
- cid_521951
- GTPL7159
- orb1310687
- 2-Butoxy-N-(2-(diethylamino)ethyl)cinchoninamide
- 2-Butoxy-N-(beta-diethylaminoethyl)cinchoninamide
- 2-N-Butoxy-N-(2-diethylaminoethyl)cinchoninamide
- N-(2-(Diethylamino)ethyl)-2-butoxycinchoninamide
- DIBUCAINE [USP IMPURITY]
- SCHEMBL29810833
- 2-Butoxyquinoline-4-carboxylic acid diethylaminoethylamide
- BDBM48532
- CTK8F9135
- HY-B0552R
- KBio1_000332
- KBio2_001408
- KBio2_003976
- KBio2_006544
- KBio3_001387
- 2-butoxy-N-(2-(diethylamino)ethyl)quinoline-4-carboxamide
- alpha-Butyloxycinchoninic acid diethylethylenediamide
- BRN 0275489
- C05AD04
- CID3025
- D04AB02
- DIBUCAINE [USP MONOGRAPH]
- N01BB06
- S01HA06
- S02DA04
- sovcainum (for the hydrochloride)
- NINDS_000332
- NSC159055
- Cvs Hemorrhoidal Topical Analgesic
- HMS1568O13
- HMS2095O13
- HMS2233F03
- HMS3370I12
- HMS3712O13
- HMS3886I10
- HMS5084J14
- ACT04722
- alpha-Butyloxycinchonic acid-gamma-diethylethylenediamine
- CID:3025
- HY-B0552
- MSK10140
- ZINC1530939
- 2-Butoxy-N-[2-(diethylamino)ethyl]cinchoninamide
- CAS-85-79-0
- Tox21_110381
- 2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide
- EBC-26667
- NCGC00016338-01
- s5534
- STL483757
- 61-12-1 (Dibucaine Hydrochloride)
- SMR000058391
- AKOS015897110
- C20-H29-N3-O2
- Tox21_110381_1
- 2-butoxy-N-(alpha-diethylaminoethyl)cinchoninamide
- AC-2093
- CCG-220076
- CS-2656
- CS-O-06228
- DB00527
- FC33247
- J3.887C
- 4-Quinolinecarboxamide, 2-butoxy-N-[2-(diethylamino)ethyl]-
- IDI1_000332
- KS-00000L64
- Cinchoninamide, 2-butoxy-N-(2-(diethylamino)ethyl)-
- NCGC00016338-02
- NCGC00016338-03
- NCGC00016338-04
- NCGC00016338-05
- NCGC00016338-06
- NCGC00016338-07
- NCGC00016338-10
- WLN: T66 BNJ CO4 EVM2N2&2
- AJ-26713
- AK161941
- AN-14281
- AS-17426
- BAS 00401270
- LS-53768
- N-[2-(Diethylamino)ethyl]-2-butoxycinchoninamide
- SC-24437
- SMR000058369
- SY107339
- 2-butoxy-N-(2-diethylaminoethyl)cinchoninamide
- 2-butoxy-N-(2-diethylaminoethyl)quinoline-4-carboxamide
- 4-Quinolinecarboxamide, 2-butoxy-N-(2-(diethylamino)ethyl)-
- SBI-0051340.P003
- SID:134223451
- DB-056882
- 2-Butoxy-quinoline-4-carboxylic acid (2-diethylamino-ethyl)-amide
- A8407
- AB00053453
- B3373
- Dibucaine Topical Anesthetic 1% Hemorrhoidal
- FT-0603086
- NS00010344
- ST24046324
- ST51037211
- V0074
- 4-22-00-02284 (Beilstein Handbook Reference)
- 2-Butoxy-N-(.beta.-diethylaminoethyl)cinchoninamide
- C07879
- D00733
- .alpha.-Butyloxycinchoninic acid diethylethylenediamide
- AB00053453_24
- AB00053453_25
- Cinchoninamide, 2-butoxy-N-[2-(diethylamino)ethyl]-
- 2-Butoxy-N-(beta.-diethylaminoethyl)cinchoninamide
- D003992
- EN300-18536764
- F462730
- Q417603
- SR-01000003037
- I08-0059
- SR-01000003037-6
- BRD-K99121711-001-03-5
- BRD-K99121711-003-02-3
- BRD-K99121711-003-12-2
- BRD-K99121711-003-19-7
- BRD-K99121711-003-20-5
- quinoline, 2-butoxy-4-(2-diethylaminoethylcarbamoyl)-
- 2-BUTOXY-N-(2-(DIETHYLAMINO)ETHYL)-4-QUINOLINECARBOXAMIDE
- 4-Quinolinecarboxamide,2-butoxy-N-[2-(diethylamino)ethyl]-
- N-[2-(diethylamino)ethyl](2-butoxy(4-quinolyl))carboxamide
- 2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide #
- 2-butoxy-N-[2-(diethylamino)ethyl]cinchoninamide;hydrochloride
- 2-butoxy-N-(2-(diethylamino)ethyl)quinoline-4-carboximidic acid
- 2-butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboximidic acid
- 4-QUINOLINECARBOXAMIDE, 2-BUTOXY-N-(2-(DIETHYLAMINO)ETHYL)
- 2-butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide;hydrochloride
- 2-butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide;hydrochloride
- QUINOLINE,2-BUTOXY,4-CARBOXY,(N-TRIETHYLAMINO) AMIDE CINCHOCAIN
- QUINOLINE,2-BUTOXY,4-CARBOXY,(N-TRIETHYLAMINO) AMIDE CINCHOCAIN
- 111470-99-6
- 2-[3-chloro-4-[(2-chloro-4-nitrophenyl)diazenyl]-N-[2-(ethylcarbamoyloxy)ethyl]anilino]ethyl N-ethylcarbamate
- 201-632-1
- 4-Quinolinecarboxamide, 2-butoxy-N-[2-(diethylamino)ethyl]-; Cinchoninamide, 2-butoxy-N-[2-(diethylamino)ethyl]- (8CI); 2-Butoxy-N-[2-(diethylamino)ethyl]-4-quinolinecarboxamide; 2-Butoxy-N-[2-(diethylamino)ethyl]cinchoninamide; 2-Butoxy-N-[2-(diethylamino)ethyl]quinoline-4-carboxamide; Cinchocaine; Dermacaine; Dibucaine; Dibucaine base; N-[2-(Diethylamino)ethyl]-2-butoxycinchoninamide; NSC 159055; Nupercainal; Nupercaine; Percamine
- 61-12-1
- 6323-77-9
- InChI=1/C20H29N3O2/c1-4-7-14-25-19-15-17(16-10-8-9-11-18(16)22-19)20(24)21-12-13-23(5-2)6-3/h8-11,15H,4-7,12-14H2,1-3H3,(H,21,24